Common Stock, par value $.01 per share
- Symbol
- NSYS
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 2.02, 9.01 · 8-K
NSYSNASDAQEQUITYCurrent
Item 2.02 Results of Operations and Financial Condition The Registrant issued a news release on November 12, 2026, entitled “Nortech Systems Reports Third Quarter Results” regarding its consolidated results and financial condition for the third quarter ended September 30, 2026. A copy of this news release is attached hereto as Exhibit 99.1.
Press release in this filing
Nortech Systems Reports Third Quarter Results →Nortech Systems is a leading provider of design and manufacturing solutions for complex electromedical devices, electromechanical systems, assemblies, and components. Nortech primarily serves the medical imaging, medical device, aerospace & defense, and industrial markets. Its design services span concept development to commercial design, and include medical device, software, electrical, mechanical, and biomedical engineering. Its manufacturing and supply chain capabilities are vertically integrated around wire, cable, and interconnect assemblies, printed circuit board assemblies, as well as system-level assembly, integration, and final test. Headquartered in Maple Grove, Minn., Nortech currently has six manufacturing locations and design centers across the U.S., Latin America, and Asia. Nortech Systems is traded on the NASDAQ Stock Market under the symbol NSYS. Nortech’s website is www.nortechsys.com.
NORTECH SYSTEMS INCORPORATED · 8-K · Filed 2026-11-12
Exhibit 99.1 Nortech Systems Reports Third Quarter Results MINNEAPOLIS - November 12, 2026 - Nortech Systems Incorporated (Nasdaq: NSYS) (“Nortech” or the “Company”), a leading provider of engineering and manufacturing solutions for complex electromedical and electromechanical products serving the medical imaging, medical device, industrial, and aerospace & defense markets, reported financial results for the third quarter ended September 30, 2026. 2026 Q3 Highlights: Net sales of $33.0 million in Q3 2026 vs. $30.5 million in Q3 2025 Net income of $637 thousand, or $0.21 per diluted share in Q3 2026 vs. net loss of $(146) thousand, or $(0.05) per diluted share in Q3 2025 Adjusted earnings before interest, taxes, depreciation, and amortization (“Adjusted EBITDA”) of $2.0 million in Q3 2026 vs. $1.3 million in Q3 2025 90-day backlog of $31.5 million as of September 30, 2026 vs. $31.3 million as of September 30, 2025 Total backlog of $92.8 million as of September 30, 2026, up 20% from September 30, 2025 Management Commentary “Our third quarter results reflect continued execution of our business strategy,” said President & CEO, Jay D. Miller. “We are deepening engineer…
Open exhibit ↗